Québec is facing one of the most serious escalations of drug-related harm in its history. While overdose deaths have declined in most Canadian provinces, Québec is moving in the opposite direction. In 2024, there were 645 confirmed opioid-related deaths in the province — up from 536 in 2023, and more than double the number recorded in 2022, according to the Canadian Centre on Substance Use and Addiction. Québec’s public health institute has described 2024 as the worst year on record for overdose deaths in the province.
The province has traditionally had a cocaine-driven drug market, but opioids — particularly fentanyl and illicit benzodiazepines — are now driving a sharp rise in deaths. Urgences-Santé in Montréal alone administered naloxone over 1,000 times in 2024, with fentanyl implicated in a growing proportion of those calls. Experts at Université de Montréal describe Québec as “catching up” to a crisis that has devastated other provinces for years — and the pace of that acceleration is alarming.
Beyond opioids, alcohol, cocaine, stimulants, benzodiazepines, and prescription drug misuse affect tens of thousands of Québec residents each year, cutting across income levels, communities, and demographics — urban and regional alike.
The public treatment system is under enormous pressure. For someone who has found the courage to ask for help, waiting weeks or months for a publicly funded bed is not just frustrating — it can be fatal. Recovery windows are fragile, and private treatment allows you to act on them immediately.